戻る Agenda
Session 8: Promoting to Special Populations: Beginning with the End in Mind
Session Chair(s)
Moulakshi Roychowdhury, JD, PharmD
Global Head, Regulatory Affairs, Advertising & Promotion, Allergan Aesthetics
AbbVie, United States
As the practice of Medicine becomes more individualized, so must the generation of data to make claims as well as how we reach our special target populations. This session will explore legislative mandates for clinical trial diversity, which will lead to the generation of data for product approval and promotion. We will also explore how patients and generations are evolving in how they seek and digest information and its direct impact on how companies promote to appropriately reach their target audiences, potentially requiring new methods for adequate provision. This session will lead the audience to think more strategically about how to meet our special populations where they are seeking information within the bounds of regulations.
Learning Objective :
- Analyze existing legislation for clinical trial diversity to generate data for promotion
- Evaluate whether we are reaching special populations when and where they are seeking product information
- Assess promotional opportunities and identify alternative methods to provide adequate provision to younger audiences (e.g., QR codes vs. paper)
Speaker(s)
Promoting to Special Populations: Diversity in Clinical Trials Initiatives
Denise Sanchez, JD, MA, MS
Opus Regulatory Inc., United States
Principal Consultant
Speaker
Hillary Gurber
Google, United States
Not Provided
Speaker
Jasson W Gilmore
Independent, United States
Pharma & Digital Media Executive, Start-up Founder & Adviser